143 related articles for article (PubMed ID: 15947489)
1. Mechanism of the eosinophilic differentiation of HL-60 clone 15 cells induced by n-butyrate.
Ishihara K; Hong J; Zee O; Ohuchi K
Int Arch Allergy Immunol; 2005; 137 Suppl 1():77-82. PubMed ID: 15947489
[TBL] [Abstract][Full Text] [Related]
2. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.
Ishihara K; Hong J; Zee O; Ohuchi K
Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors.
Ishihara K; Takahashi A; Kaneko M; Sugeno H; Hirasawa N; Hong J; Zee O; Ohuchi K
Life Sci; 2007 Mar; 80(13):1213-20. PubMed ID: 17258775
[TBL] [Abstract][Full Text] [Related]
4. Eosinophil cell lines.
Ishihara K
Methods Mol Biol; 2014; 1178():45-51. PubMed ID: 24986606
[TBL] [Abstract][Full Text] [Related]
5. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis.
Chen J; Du C; Kang J; Wang J
Chem Biol Interact; 2008 Jan; 171(1):26-36. PubMed ID: 17961528
[TBL] [Abstract][Full Text] [Related]
6. Mechanism for the decrease in the FIP1L1-PDGFRalpha protein level in EoL-1 cells by histone deacetylase inhibitors.
Ishihara K; Kaneko M; Kitamura H; Takahashi A; Hong JJ; Seyama T; Iida K; Wada H; Hirasawa N; Ohuchi K
Int Arch Allergy Immunol; 2008; 146 Suppl 1():7-10. PubMed ID: 18504399
[TBL] [Abstract][Full Text] [Related]
7. The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines.
Savickiene J; Borutinskaite VV; Treigyte G; Magnusson KE; Navakauskiene R
Eur J Pharmacol; 2006 Nov; 549(1-3):9-18. PubMed ID: 16978604
[TBL] [Abstract][Full Text] [Related]
8. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
[TBL] [Abstract][Full Text] [Related]
9. Discordant effects of butyrate analogues on erythroleukemia cell proliferation, differentiation and histone deacetylase.
Lea MA; Tulsyan N
Anticancer Res; 1995; 15(3):879-83. PubMed ID: 7645975
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells.
Karasawa Y; Okisaka S
Jpn J Ophthalmol; 2004; 48(6):542-51. PubMed ID: 15592778
[TBL] [Abstract][Full Text] [Related]
11. Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry.
Naldi M; Andrisano V; Fiori J; Calonghi N; Pagnotta E; Parolin C; Pieraccini G; Masotti L
J Chromatogr A; 2006 Sep; 1129(1):73-81. PubMed ID: 16887128
[TBL] [Abstract][Full Text] [Related]
12. Keratin 23 (K23), a novel acidic keratin, is highly induced by histone deacetylase inhibitors during differentiation of pancreatic cancer cells.
Zhang JS; Wang L; Huang H; Nelson M; Smith DI
Genes Chromosomes Cancer; 2001 Feb; 30(2):123-35. PubMed ID: 11135429
[TBL] [Abstract][Full Text] [Related]
13. Butyrate-induced histone hyperacetylation in human and mouse cells: estimation of putative sites of histone acetylation in vivo.
Pantazis P; Bonner WM
J Cell Biochem; 1982; 20(3):225-35. PubMed ID: 7169496
[TBL] [Abstract][Full Text] [Related]
14. Increased histone acetylation and deacetylation in rat ascites hepatoma cells.
Horiuchi K; Fujimoto D; Fukushima M; Kanai K
Cancer Res; 1981 Apr; 41(4):1488-91. PubMed ID: 6163524
[TBL] [Abstract][Full Text] [Related]
15. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species.
Kang J; Chen J; Shi Y; Jia J; Zhang Y
Biochem Pharmacol; 2005 Apr; 69(8):1205-13. PubMed ID: 15794941
[TBL] [Abstract][Full Text] [Related]
16. Response of retinoic acid-resistant KG1 cells to combination of retinoic acid with diverse histone deacetylase inhibitors.
Savickiene J; Treigyte G; Magnusson KE; Navakauskiene R
Ann N Y Acad Sci; 2009 Aug; 1171():321-33. PubMed ID: 19723072
[TBL] [Abstract][Full Text] [Related]
17. Roles of histone acetyltransferases and deacetylases in gene regulation.
Kuo MH; Allis CD
Bioessays; 1998 Aug; 20(8):615-26. PubMed ID: 9780836
[TBL] [Abstract][Full Text] [Related]
18. Mechanism for the differentiation of EoL-1 cells into eosinophils by histone deacetylase inhibitors.
Kaneko M; Ishihara K; Takahashi A; Hong J; Hirasawa N; Zee O; Ohuchi K
Int Arch Allergy Immunol; 2007; 143 Suppl 1():28-32. PubMed ID: 17541273
[TBL] [Abstract][Full Text] [Related]
19. C/EBPα and PU.1 are involved in distinct differentiation responses of acute promyelocytic leukemia HL-60 and NB4 cells via chromatin remodeling.
Savickiene J; Treigyte G; Vistartaite G; Tunaitis V; Magnusson KE; Navakauskiene R
Differentiation; 2011 Jan; 81(1):57-67. PubMed ID: 20864248
[TBL] [Abstract][Full Text] [Related]
20. [Assay for inhibitory activity of histone deacetylase].
Yoshida M
Gan To Kagaku Ryoho; 2004 Apr; 31(4):507-11. PubMed ID: 15114691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
